Package 71335-2634-3

{"route": ["ORAL"], "spl_id": "d38d8624-94b7-4595-a3d8-776e48c33755", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898353"], "spl_set_id": ["d058e426-8786-4fd3-a771-992e4558c135"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (71335-2634-1)", "package_ndc": "71335-2634-1", "marketing_start_date": "20250602"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71335-2634-2)", "package_ndc": "71335-2634-2", "marketing_start_date": "20250602"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71335-2634-3)", "package_ndc": "71335-2634-3", "marketing_start_date": "20250602"}, {"sample": false, "description": "100 CAPSULE in 1 BOTTLE (71335-2634-4)", "package_ndc": "71335-2634-4", "marketing_start_date": "20250602"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "71335-2634_d38d8624-94b7-4595-a3d8-776e48c33755", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "71335-2634", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA078466", "marketing_category": "ANDA", "marketing_start_date": "20100205", "listing_expiration_date": "20261231"}